Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q91807662)
Watch
English
Type 1 interferons as a potential treatment against COVID-19
scientific article published on 07 April 2020
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PMCID
7138382
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32275914%20AND%20SRC:MED&resulttype=core&format=json
retrieved
24 April 2020
title
Type 1 interferons as a potential treatment against COVID-19
(English)
1 reference
stated in
Europe PubMed Central
PMCID
7138382
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32275914%20AND%20SRC:MED&resulttype=core&format=json
retrieved
24 April 2020
main subject
COVID-19
1 reference
based on heuristic
inferred from title
SARS-CoV-2
1 reference
based on heuristic
inferred from title
author
Yazdan Yazdanpanah
series ordinal
3
object named as
Yazdan Yazdanpanah
1 reference
stated in
Europe PubMed Central
PMCID
7138382
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32275914%20AND%20SRC:MED&resulttype=core&format=json
retrieved
24 April 2020
France Mentré
series ordinal
4
object named as
France Mentre
1 reference
stated in
Europe PubMed Central
PMCID
7138382
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32275914%20AND%20SRC:MED&resulttype=core&format=json
retrieved
24 April 2020
author name string
Erwan Sallard
series ordinal
1
1 reference
stated in
Europe PubMed Central
PMCID
7138382
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32275914%20AND%20SRC:MED&resulttype=core&format=json
retrieved
24 April 2020
François-Xavier Lescure
series ordinal
2
1 reference
stated in
Europe PubMed Central
PMCID
7138382
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32275914%20AND%20SRC:MED&resulttype=core&format=json
retrieved
24 April 2020
Nathan Peiffer-Smadja
series ordinal
5
1 reference
stated in
Europe PubMed Central
PMCID
7138382
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32275914%20AND%20SRC:MED&resulttype=core&format=json
retrieved
24 April 2020
publication date
7 April 2020
1 reference
stated in
Europe PubMed Central
PMCID
7138382
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32275914%20AND%20SRC:MED&resulttype=core&format=json
retrieved
24 April 2020
published in
Antiviral Research
1 reference
stated in
Europe PubMed Central
PMCID
7138382
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32275914%20AND%20SRC:MED&resulttype=core&format=json
retrieved
24 April 2020
volume
178
1 reference
stated in
Europe PubMed Central
PMCID
7138382
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32275914%20AND%20SRC:MED&resulttype=core&format=json
retrieved
24 April 2020
page(s)
104791
1 reference
stated in
Europe PubMed Central
PMCID
7138382
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32275914%20AND%20SRC:MED&resulttype=core&format=json
retrieved
24 April 2020
cites work
COVID-19 illness in native and immunosuppressed states: A clinical-therapeutic staging proposal
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7138382
retrieved
23 February 2021
The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from China
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7138382
retrieved
23 February 2021
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7138382
retrieved
23 February 2021
Compounds with therapeutic potential against novel respiratory 2019 coronavirus
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7138382
retrieved
23 February 2021
Discovering drugs to treat coronavirus disease 2019 (COVID-19)
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7138382
retrieved
23 February 2021
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7138382
retrieved
23 February 2021
Effect of Intravenous Interferon β-1a on Death and Days Free From Mechanical Ventilation Among Patients With Moderate to Severe Acute Respiratory Distress Syndrome: A Randomized Clinical Trial
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7138382
retrieved
23 February 2021
Diagnosis and treatment of 2019 novel coronavirus infection in children: a pressing issue
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7138382
retrieved
23 February 2021
Drug treatment options for the 2019-new coronavirus (2019-nCoV)
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7138382
retrieved
23 February 2021
Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7138382
retrieved
23 February 2021
IFN-I response timing relative to virus replication determines MERS coronavirus infection outcomes
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7138382
retrieved
23 February 2021
Treatment of Middle East Respiratory Syndrome with a combination of lopinavir-ritonavir and interferon-β1b (MIRACLE trial): study protocol for a randomized controlled trial.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7138382
retrieved
23 February 2021
Interferon β for Multiple Sclerosis
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7138382
retrieved
23 February 2021
Treatment With Lopinavir/Ritonavir or Interferon-β1b Improves Outcome of MERS-CoV Infection in a Nonhuman Primate Model of Common Marmoset
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7138382
retrieved
23 February 2021
IFN-α2a or IFN-β1a in combination with ribavirin to treat Middle East respiratory syndrome coronavirus pneumonia: a retrospective study
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7138382
retrieved
23 February 2021
Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: a retrospective cohort study.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7138382
retrieved
23 February 2021
Interferon-stimulated genes: a complex web of host defenses
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7138382
retrieved
23 February 2021
The effect of intravenous interferon-beta-1a (FP-1201) on lung CD73 expression and on acute respiratory distress syndrome mortality: an open-label study.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7138382
retrieved
23 February 2021
Attenuation and restoration of severe acute respiratory syndrome coronavirus mutant lacking 2'-o-methyltransferase activity
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7138382
retrieved
23 February 2021
Ribavirin and interferon therapy in patients infected with the Middle East respiratory syndrome coronavirus: an observational study
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7138382
retrieved
23 February 2021
Interferon-β and mycophenolic acid are potent inhibitors of Middle East respiratory syndrome coronavirus in cell-based assays
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7138382
retrieved
23 February 2021
Broad-spectrum antivirals for the emerging Middle East respiratory syndrome coronavirus
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7138382
retrieved
23 February 2021
Inhibition of novel β coronavirus replication by a combination of interferon-α2b and ribavirin
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7138382
retrieved
23 February 2021
SARS coronavirus pathogenesis: host innate immune responses and viral antagonism of interferon
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7138382
retrieved
23 February 2021
A randomized controlled trial of low-dose recombinant human interferons alpha-2b nasal spray to prevent acute viral respiratory infections in military recruits
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7138382
retrieved
23 February 2021
Interferon and cytokine responses to SARS-coronavirus infection
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7138382
retrieved
23 February 2021
Severe acute respiratory syndrome coronavirus ORF6 antagonizes STAT1 function by sequestering nuclear import factors on the rough endoplasmic reticulum/Golgi membrane
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7138382
retrieved
23 February 2021
Severe acute respiratory syndrome coronavirus open reading frame (ORF) 3b, ORF 6, and nucleocapsid proteins function as interferon antagonists
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7138382
retrieved
23 February 2021
SARS: systematic review of treatment effects
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7138382
retrieved
23 February 2021
IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7138382
retrieved
23 February 2021
Increased sensitivity of SARS-coronavirus to a combination of human type I and type II interferons.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7138382
retrieved
23 February 2021
Ribavirin and interferon-beta synergistically inhibit SARS-associated coronavirus replication in animal and human cell lines.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7138382
retrieved
23 February 2021
Interferon-beta and interferon-gamma synergistically inhibit the replication of severe acute respiratory syndrome-associated coronavirus (SARS-CoV).
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7138382
retrieved
23 February 2021
In vitro susceptibility of 10 clinical isolates of SARS coronavirus to selected antiviral compounds.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7138382
retrieved
23 February 2021
Interferon-beta 1a and SARS coronavirus replication
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7138382
retrieved
23 February 2021
Interferon alfacon-1 plus corticosteroids in severe acute respiratory syndrome: a preliminary study
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7138382
retrieved
23 February 2021
Description and clinical treatment of an early outbreak of severe acute respiratory syndrome (SARS) in Guangzhou, PR China
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7138382
retrieved
23 February 2021
Receptor-mediated pharmacokinetic/pharmacodynamic model of interferon-beta 1a in humans
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7138382
retrieved
23 February 2021
Antiviral actions of interferons
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=7138382
retrieved
23 February 2021
Identifiers
DOI
10.1016/J.ANTIVIRAL.2020.104791
1 reference
stated in
Europe PubMed Central
PMCID
7138382
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32275914%20AND%20SRC:MED&resulttype=core&format=json
retrieved
24 April 2020
COVIDWHO ID
covidwho-49066
0 references
Dimensions Publication ID
1126273921
1 reference
stated in
Dimensions COVID-19 publications, datasets and clinical trials
DOI
10.6084/M9.FIGSHARE.11961063
retrieved
28 May 2020
PMCID
7138382
1 reference
stated in
Europe PubMed Central
PMCID
7138382
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32275914%20AND%20SRC:MED&resulttype=core&format=json
retrieved
24 April 2020
PubMed ID
32275914
1 reference
stated in
Europe PubMed Central
PMCID
7138382
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32275914%20AND%20SRC:MED&resulttype=core&format=json
retrieved
24 April 2020
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit